Normal
16
1
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.3%
1 terminated out of 16 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
Postural and Shoulder Function Norms
To Assess Skin Safety of Test Product(s) by Patch Test on Adult Healthy Human Subjects
Retinal OCTA for Microvascular Dysfunction Evaluation and Outcome Prediction in MINOCA Patients
Cardiometabolic Properties of Omega-3 Functionalized With Hydroxytyrosol
Determining How Quickly Progesterone Slows LH Pulse Frequency
Investigation of the Possibility of Determining Cerebrovascular Disease Based on Hemodynamic Information of Localized Brain Regions
Exploratory Study on Artifact Denoising of Cerebral Blood Flow and EEG Data in Ambulance Settings
TRK-3 Performance of Pachymetry
Optic Disc Photograph Collection Study
Normal Blood, Bone Marrow and Buccal Mucosa Protocol
P200TE and Predicate Agreement and Precision Study
P200TE Agreement and Precision Study
Study: Manometry With & Without Lidocaine
A Crossover Trial of Chitosan Oligosaccharide on Post Prandial Glucose Control in Subjects With Normal, IFG and IGT
System for Ocular Oxygen Measurement
Atopy Patch Test in Normal Population : Pilot Study